Aegis Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aegis Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3037
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aegis Therapeutics LLC (Aegis Therapeutics) is a drug-delivery and drug-formulation technologies company that commercializes drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and biopharmaceutical companies. The company offers Intravail, a drug delivery technology that enables the non-invasive delivery of a broad range of protein, peptide, and non-peptide drugs. It also provides ProTek, a protein stabilization technology to create homogeneous, stable, aqueous or lyophilized dosage forms for peptide or protein therapeutics; and Aegis Hydrogel, a proprietary absorption-enhancing self-assembling aqueous hydrogels useful for transdermal drug delivery, or for transmucosal applications. Aegis Therapeutics is headquartered in San Diego, California, the US.

Aegis Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Opiant Pharma Enters into Licensing Agreement with Aegis Therapeutics 10
Dauntless Pharma Enters into Licensing Agreement with Aegis Therapeutics 12
Biodel Terminates Licensing Agreement With Aegis Therapeutics For ProTek And Intravail Technologies 13
Aegis Therapeutics LLC – Key Competitors 14
Aegis Therapeutics LLC – Key Employees 15
Aegis Therapeutics LLC – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aegis Therapeutics LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Opiant Pharma Enters into Licensing Agreement with Aegis Therapeutics 10
Dauntless Pharma Enters into Licensing Agreement with Aegis Therapeutics 12
Biodel Terminates Licensing Agreement With Aegis Therapeutics For ProTek And Intravail Technologies 13
Aegis Therapeutics LLC, Key Competitors 14
Aegis Therapeutics LLC, Key Employees 15

List of Figures
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Aegis Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Empresaria Group plc (EMR):企業の財務・戦略的SWOT分析
    Empresaria Group plc (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SPI Pharma Inc:企業の戦略的SWOT分析
    SPI Pharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Reach Subsea ASA (REACH):企業の財務・戦略的SWOT分析
    Reach Subsea ASA (REACH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • RHÖN-KLINIKUM AG:企業の戦略・SWOT・財務情報
    RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report Summary RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • At Home Group Inc. (HOME):企業の財務・戦略的SWOT分析
    At Home Group Inc. (HOME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kimal plc-医療機器分野:企業M&A・提携分析
    Summary Kimal plc (Kimal) is a medical equipment company that develops, manufactures and markets customised procedure packs and vascular access devices. The company’s products include soft tissue biopsy needles, bone marrow biopsy needles, catheter accessories, catheter lock solution, closure device …
  • IRWIN Industrial Tool Co:企業の戦略的SWOT分析
    IRWIN Industrial Tool Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • BioCardia Inc:製品パイプライン分析
    Summary BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally processed bone marrow cells; and CardiA …
  • NWS Holdings Limited:企業の戦略・SWOT・財務情報
    NWS Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary NWS Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Weyerhaeuser Co (WY):企業の財務・戦略的SWOT分析
    Weyerhaeuser Co (WY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Canada Energy Partners Inc (CE):企業の財務・戦略的SWOT分析
    Summary Canada Energy Partners Inc (Canada Energy) is a natural gas exploration and development company. The company concentrates on mid-stream supplying of water disposal services, development of a wellbore mining technology and energy or mineral exploring. Canada Energy develops a wellbore mining …
  • Power Grid Corporation of India Limited:企業の戦略・SWOT・財務分析
    Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report Summary Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Chariot Oil & Gas Ltd (CHAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Chariot Oil & Gas Ltd (CHAR) is an oil and gas exploration company that create transformational stakeholder value through the discovery of material accumulations of hydrocarbons. The company provides services such as drilling and extracting services for oil and gas resources. It also offers …
  • Rum Group for Transportation & Tourism Investment:戦略・SWOT・企業財務分析
    Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report Summary Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Exfo Inc.
    Exfo Inc. - Strategy, SWOT and Corporate Finance Report Summary Exfo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Bionik Laboratories Corp (BNKL):企業の製品パイプライン分析2018
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body …
  • UGI Corporation:企業の戦略・SWOT・財務情報
    UGI Corporation - Strategy, SWOT and Corporate Finance Report Summary UGI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Delta Air Lines, Inc.:企業のM&A・事業提携・投資動向
    Delta Air Lines, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delta Air Lines, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Phagelux Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Phagelux Inc (Phagelux) is an anti-infectives company that provides antibacterial products and solutions. The company uses phage lysis enzymes and biological agents for the treatment of antibiotic resistant bacteria and related diseases in human beings and crops. Its product portfolio includ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆